neurodegenerative diseases - search results

JPND, the largest global collaborative initiative for neurodegenerative disease research, creates a major impact on neurodegenerative research funding in Europe.

Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.

Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.

Prof Monica Di Luca, President, European Brain Council, highlights the importance of continuous prioritisation and attention to brain research during the COVID-19 pandemic.

Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for degenerative diseases.

Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders

Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?

Scientists from the National Institutes of Health (NIH) compared the genetic clocks of normal and mutant flies to understand the link between neurodegenerative disorders such as Alzheimer’s disease and the ageing process

Professor Serena Carra and her collaborators are investigating the important role of small heat shock proteins in age-related neurodegenerative diseases Cells are frequently exposed to stress conditions that can damage their proteome, with consequences for their viability. To maintain a healthy proteome and preserve cell function, cells evolved a protein...

Professor Duncan McHale discusses neurodegenerative disease research... Neurodegenerative diseases are a growing global challenge as medical advances ensures more individuals live longer.  By 2020 there will be > 40 million individuals in the world with Alzheimer’s disease and by 2040 without the development of truly disease modifying drugs this will...

Welcome to the April 2019 edition of North America Analysis. One of the highlights in this issue is the special focus we have on neurodegenerative diseases, which includes comment from Jeffrey Borenstein, of the Brain & Behavior Research Foundation (BBRF).

Prof Dr Regina Fluhrer from Biomedical Center (BMC), Ludwig Maximilians University of Munich (LMU) & German Center for Neurodegenerative Diseases (DZNE) shares her expertise on the field of intramembrane proteases, focussing on regulation of cellular pathways

Naoko Tanese from New York University explores how monitoring gene expression can be used to treat neurodegenerative diseases such as Huntington's

Researchers from the University of Technology Sydney (UTS), UNSW Sydney, and the Agency for Science, Technology and Research in Singapore have found a link between air pollution and Alzheimer's disease.

Researchers at the Buck Institute have revealed a link between dietary restriction, a gene called OXR1, and the preservation of brain health.

Fibrosis was once considered irreversible, resulting from chronic organ damage; Ken-Ichi Kobayashi from Notre Dame Seishin University tells us why the possibility of treatment to reverse the disease is gaining attention.

Parkinson’s disease, a progressive neurodegenerative disorder, poses significant challenges for both patients and researchers. In a recent interview with Henri Huttunen from Herantis Pharma Plc, we delved into the intricacies of their potential novel disease-modifying therapy, HER-096.

Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, examines the link between white matter lesions and neurodegeneration.

The U.S.-based PANTHER program is pioneering a physics-based approach to TBI for quantitatively and deterministically linking the physics of a head insult to the resulting biological injury response. Christian Franck and Alice Lux Fawzi discuss.

Regular exercise is a critical step in maintaining healthy physiology and ensuring healthy aging. However, there are many diseases and conditions that make exercise inaccessible or reduce its efficacy. The Wessells lab studies exercise and the pathways it works through to identify key molecules required for a proper exercise response.